Tucaresol

妥卡雷琐

Report date: 2023/04/25 15:45:47
NME

Base Information

Drug NameTucaresol
Drug Alias Name589C589C80BW-589CBW-A589CBW-589C80
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTh1 cells stimulantsImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItaly
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A